Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
AMRUTANJAN.NSthis companyAmrutanjan Health Care Limited	₹519.85	24.65×	3.86×	2.84×	18.44×	18.1%	37.4%	13.8%	11.5%	15.6%	13.5%	-0.2%	0×	-0.42×	355.72×	2.31×	0.9%	4	—	2	C+
BLBLISSGVS.BOBliss GVS Pharma Limited	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
BLISSGVS.NSBliss GVS Pharma Limited	₹654.75	18.76×	2.03×	2.61×	10.25×	-99.6%	54.2%	14.1%	13.9%	10.8%	7.3%	3.4%	0.02×	-0.06×	10.87×	4.02×	0.4%	6	17.76	3	B
JAJAGSNPHARM.BOJagsonpal Pharmaceuticals Limited	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
JAGSNPHARM.NSJagsonpal Pharmaceuticals Limited	₹217.42	29.01×	4.53×	4.35×	18.35×	83.7%	63.7%	16.9%	15.0%	15.6%	12.6%	3.7%	0.03×	-0.03×	47.31×	5.06×	1.3%	5	13.66	4	A
MOREPENLAB.NSMorepen Laboratories Limited	₹99.15	21.5×	1.64×	1.13×	12.61×	-82.7%	37.8%	4.9%	5.3%	7.6%	4.7%	-7.1%	0.17×	0.8×	5.43×	2.37×	0.5%	5	5.38	3	B
Peer median	—	21.5×	2.03×	2.61×	12.61×	-82.7%	54.2%	14.1%	13.9%	10.8%	7.3%	3.4%	0.03×	-0.03×	10.87×	4.02×	0.5%	5	13.66	3	—